Therefore, in ADG, exploring the expression levels of CD47 and TIGIT and their prognostic relationships, as well as the relationship between pTERT mutations and MGMT methylation status and prognosis, may provide some valuable clues for the therapy of ADG. Here, CD47 is linked to isolated congenital adermatoglyphia.